{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T16:35:10Z","timestamp":1782750910335,"version":"3.54.5"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T00:00:00Z","timestamp":1630972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-17-0505"],"award-info":[{"award-number":["APVV-17-0505"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["VEGA 1\/0649\/21"],"award-info":[{"award-number":["VEGA 1\/0649\/21"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Fecal microbiota transplantation has been primarily investigated as a therapeutic tool for a number of gut disorders. Optimistic results from clinical studies on Clostridium difficile infection, inflammatory bowel disease and irritable bowel syndrome have stimulated the expansion of possible indications in which FMT might represent a game changing approach. Microbial dysbiosis was shown in a number of non-gastrointestinal disorders. Moreover, FMT was proven to be effective in therapy of numerous animal models of disease. However, only a proportion of these disorders have been addressed in clinical studies using FMT. These include obesity, non-alcoholic fatty liver disease, cardiovascular inflammation and neurological disorders such as autism, depression and Parkinson's disease. Results from preclinical and clinical studies also outlined possible molecular mechanisms that contribute to alleviation of the disease. These range from increasing the circulating levels of microbial metabolites (trimethylamine N-oxide, lipopolysaccharide, short chain fatty acids) to stimulation of the enteric nervous system. Several methodological shortcomings are still to be addressed; however, positive results of the clinical studies indicate that further investigation of FMT as a therapeutic tool for non-gastrointestinal disorders can be expected in upcoming years.<\/jats:p>","DOI":"10.3389\/fmed.2021.665520","type":"journal-article","created":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T04:46:13Z","timestamp":1630989973000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Fecal Microbiota Transplantation as a Tool for Therapeutic Modulation of Non-gastrointestinal Disorders"],"prefix":"10.3389","volume":"8","author":[{"given":"Robert","family":"Liptak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Gromova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Gardlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"10104","DOI":"10.1038\/s41598-018-28550-3","article-title":"Analysis of the gut microbiome of rural and urban healthy indians living in sea level and high altitude areas","volume":"8","author":"Das","year":"2018","journal-title":"Sci Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.cell.2012.04.037","article-title":"Gut immune maturation depends on colonization with a host-specific microbiota","volume":"149","author":"Chung","year":"2012","journal-title":"Cell."},{"key":"B3","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3389\/fimmu.2017.00548","article-title":"Detrimental impact of microbiota-accessible carbohydrate-deprived diet on gut and immune homeostasis: an overview","volume":"8","author":"Da\u00efen","year":"2017","journal-title":"Front Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cmet.2013.02.013","article-title":"Xenobiotics and the human gut microbiome: metatranscriptomics reveal the active players","volume":"17","author":"Ursell","year":"2013","journal-title":"Cell Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e00232","DOI":"10.14309\/ctg.0000000000000232","article-title":"The gut microbiome in patients with chronic pancreatitis is characterized by significant dysbiosis and overgrowth by opportunistic pathogens","volume":"11","author":"Frost","year":"2020","journal-title":"Clin Transl Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.biopsych.2016.08.024","article-title":"Emerging roles for the gut microbiome in autism spectrum disorder","volume":"81","author":"Vuong","year":"2017","journal-title":"Biol Psychiatry."},{"key":"B7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","article-title":"Gut-brain axis: how the microbiome influences anxiety and depression","volume":"36","author":"Foster","year":"2013","journal-title":"Trends Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","article-title":"The gut microbiome in atherosclerotic cardiovascular disease","volume":"8","author":"Jie","year":"2017","journal-title":"Nat Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.1016\/j.dsx.2016.01.024","article-title":"Gut microbiome and metabolic syndrome","volume":"10","author":"Mazidi","year":"2016","journal-title":"Diabetes Metab Syndr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"592157","DOI":"10.3389\/fendo.2020.592157","article-title":"Can you trust your gut? Implicating a disrupted intestinal microbiome in the progression of NAFLD\/NASH","volume":"11","author":"Jadhav","year":"2020","journal-title":"Front Endocrinol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","article-title":"Gut microbiota modulation of chemotherapy efficacy and toxicity","volume":"14","author":"Alexander","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature15367","article-title":"Neutrophil ageing is regulated by the microbiome","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature."},{"key":"B13","first-page":"854","article-title":"Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis","volume":"44","author":"Eiseman","year":"1958","journal-title":"Surgery."},{"key":"B14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"van Nood","year":"2013","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.cmet.2017.09.008","article-title":"Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition","volume":"26","author":"Kootte","year":"2017","journal-title":"Cell Metab."},{"key":"B17","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/gutjnl-2019-318320","article-title":"Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time","volume":"69","author":"de Groot","year":"2020","journal-title":"Gut."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1003051","DOI":"10.1371\/journal.pmed.1003051","article-title":"Fecal microbiota transplantation for the improvement of metabolism in obesity: the FMT-TRIM double-blind placebo-controlled pilot trial","volume":"17","author":"Yu","year":"2020","journal-title":"PLoS Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e008342","DOI":"10.1161\/JAHA.117.008342","article-title":"Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome","volume":"7","author":"Smits","year":"2018","journal-title":"J Am Heart Assoc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/hep4.1601","article-title":"Donor fecal microbiota transplantation alters gut microbiota and metabolites in obese individuals with steatohepatitis","volume":"4","author":"Witjes","year":"2020","journal-title":"Hepatol Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1053\/j.gastro.2019.01.033","article-title":"Long-term outcomes of fecal microbiota transplantation in patients with cirrhosis","volume":"156","author":"Bajaj","year":"2019","journal-title":"Gastroenterology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/hep.30690","article-title":"Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial","volume":"70","author":"Bajaj","year":"2019","journal-title":"Hepatology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40168-016-0225-7","article-title":"Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study","volume":"5","author":"Kang","year":"2017","journal-title":"Microbiome."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1038\/s41598-019-42183-0","article-title":"Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota","volume":"9","author":"Kang","year":"2019","journal-title":"Sci Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"AB512","DOI":"10.1016\/j.gie.2019.03.857","article-title":"Fecal microbiota transplantation for children with autism spectrum disorder","volume":"89","author":"Zhao","year":"2019","journal-title":"Gastrointestinal Endoscopy."},{"key":"B27","doi-asserted-by":"publisher","first-page":"100029","DOI":"10.1016\/j.medmic.2020.100029","article-title":"Faecal microbiota transplantation alleviates symptoms of depression in individuals with irritable bowel syndrome: a case series","volume":"6","author":"Collyer","year":"2020","journal-title":"Med Microecol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e22035","DOI":"10.1097\/MD.0000000000022035","article-title":"Fecal microbiota transplantation therapy for Parkinson's disease: a preliminary study","volume":"99","author":"Xue","year":"2020","journal-title":"Medicine."},{"key":"B29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12934-021-01589-0","article-title":"Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation","volume":"20","author":"Kuai","year":"2021","journal-title":"Microb Cell Fact."},{"key":"B30","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/01.hjh.0000217840.26971.b6","article-title":"The metabolic syndrome: a glance at its history","volume":"24","author":"Sarafidis","year":"2006","journal-title":"J Hypertens."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1241214","DOI":"10.1126\/science.1241214","article-title":"Gut microbiota from twins discordant for obesity modulate metabolism in mice","volume":"341","author":"Ridaura","year":"2013","journal-title":"Science."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1210\/jc.2015-4251","article-title":"Mechanisms linking the gut microbiome and glucose metabolism","volume":"101","author":"Utzschneider","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm3312","article-title":"Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR","volume":"13","author":"Calkin","year":"2012","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0134893","DOI":"10.1371\/journal.pone.0134893","article-title":"Rescue of fructose-induced metabolic syndrome by antibiotics or faecal transplantation in a rat model of obesity","volume":"10","author":"Di Luccia","year":"2015","journal-title":"PLoS ONE."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0218143","DOI":"10.1371\/journal.pone.0218143","article-title":"Effects from diet-induced gut microbiota dysbiosis and obesity can be ameliorated by fecal microbiota transplantation: a multiomics approach","volume":"14","author":"Guirro","year":"2019","journal-title":"PLoS ONE."},{"key":"B38","doi-asserted-by":"publisher","first-page":"15625","DOI":"10.1038\/s41598-018-33893-y","article-title":"Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice","volume":"8","author":"Lai","year":"2018","journal-title":"Sci Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"9388","DOI":"10.1038\/s41598-020-64961-x","article-title":"Autologous fecal transplantation from a lean state potentiates caloric restriction effects on body weight and adiposity in obese mice","volume":"10","author":"P\u00e9rez-Matute","year":"2020","journal-title":"Sci Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature."},{"key":"B41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","article-title":"Gut microbiota dysbiosis contributes to the development of hypertension","volume":"5","author":"Li","year":"2017","journal-title":"Microbiome."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N Engl J Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1161\/CIRCRESAHA.118.313234","article-title":"A proinflammatory gut microbiota increases systemic inflammation and accelerates atherosclerosis","volume":"124","author":"Brandsma","year":"2019","journal-title":"Circ Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1161\/CIRCRESAHA.119.316394","article-title":"Intestinal flora modulates blood pressure by regulating the synthesis of intestinal-derived corticosterone in high salt-induced hypertension","volume":"126","author":"Yan","year":"2020","journal-title":"Circ Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.phrs.2018.11.042","article-title":"Fecal microbiota transplantation alleviates myocardial damage in myocarditis by restoring the microbiota composition","volume":"139","author":"Hu","year":"2019","journal-title":"Pharmacol Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fphys.2019.00231","article-title":"Critical role of the interaction gut microbiota - sympathetic nervous system in the regulation of blood pressure","volume":"10","author":"Toral","year":"2019","journal-title":"Front Physiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1038\/d41586-017-06925-2","article-title":"Disease progression: divergent paths","volume":"551","author":"DeWeerdt","year":"2017","journal-title":"Nature."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e9302","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrgastro.2010.172","article-title":"The role of the gut microbiota in nonalcoholic fatty liver disease","volume":"7","author":"Abu-Shanab","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1096\/fj.10-164921","article-title":"Germ-free C57BL\/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism","volume":"24","author":"Rabot","year":"2010","journal-title":"FASEB J."},{"key":"B51","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.chom.2016.10.016","article-title":"The liver at the nexus of host-microbial interactions","volume":"20","author":"Macpherson","year":"2016","journal-title":"Cell Host Microbe."},{"key":"B52","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jcmgh.2015.01.001","article-title":"Hepatic injury in nonalcoholic steatohepatitis contributes to altered intestinal permeability","volume":"1","author":"Luther","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development","volume":"71","author":"Mouries","year":"2019","journal-title":"J Hepatol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41598-017-01751-y","article-title":"Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11011-007-9072-3","article-title":"Neuronal cell death in hepatic encephalopathy","volume":"22","author":"Butterworth","year":"2007","journal-title":"Metab Brain Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J Hepatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"G168","DOI":"10.1152\/ajpgi.00190.2011","article-title":"Linkage of gut microbiome with cognition in hepatic encephalopathy","volume":"302","author":"Bajaj","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/apt.13406","article-title":"Introduction: understanding mechanisms of the actions of rifaximin in selected gastrointestinal diseases","volume":"43","author":"DuPont","year":"2016","journal-title":"Aliment Pharmacol Ther."},{"key":"B60","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/hepr.13300","article-title":"Rifaximin-altered gut microbiota components associated with liver\/neuropsychological functions in patients with hepatic encephalopathy: an exploratory data analysis of phase II\/III clinical trials","volume":"49","author":"Kawaguchi","year":"2019","journal-title":"Hepatol Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/1751-2980.12816","article-title":"Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: a multicenter, randomized controlled trial","volume":"20","author":"Wang","year":"2019","journal-title":"J Dig Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"6983","DOI":"10.3748\/wjg.v23.i38.6983","article-title":"Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction","volume":"23","author":"Wang","year":"2017","journal-title":"World J Gastroenterol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1128\/JCM.00845-13","article-title":"Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea","volume":"51","author":"Antharam","year":"2013","journal-title":"J Clin Microbiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/bies.201400075","article-title":"Altered brain-gut axis in autism: comorbidity or causative mechanisms?","volume":"36","author":"Mayer","year":"2014","journal-title":"Bioessays."},{"key":"B65","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41598-018-36430-z","article-title":"Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder","volume":"9","author":"Liu","year":"2019","journal-title":"Sci Rep."},{"key":"B66","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.cell.2016.10.027","article-title":"The central nervous system and the gut microbiome","volume":"167","author":"Sharon","year":"2016","journal-title":"Cell."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.cell.2019.05.004","article-title":"Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice","volume":"177","author":"Sharon","year":"2019","journal-title":"Cell."},{"key":"B68","doi-asserted-by":"publisher","first-page":"118497","DOI":"10.1016\/j.lfs.2020.118497","article-title":"The effect of fecal microbiota transplantation on autistic-like behaviors in Fmr1 KO mice","volume":"262","author":"Goo","year":"2020","journal-title":"Life Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1515\/revneuro-2017-0072","article-title":"Gut microbiome and depression: what we know and what we need to know","volume":"29","author":"Winter","year":"2018","journal-title":"Rev Neurosci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jad.2021.06.006","article-title":"Ingestion of Faecalibaculum rodentium causes depression-like phenotypes in resilient Ephx2 knock-out mice: a role of brain-gut-microbiota axis via the subdiaphragmatic vagus nerve","volume":"292","author":"Wang","year":"2021","journal-title":"J Affect Disord."},{"key":"B71","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.bbi.2015.03.016","article-title":"Altered fecal microbiota composition in patients with major depressive disorder","volume":"48","author":"Jiang","year":"2015","journal-title":"Brain Behav Immun."},{"key":"B72","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jpsychires.2016.07.019","article-title":"Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat","volume":"82","author":"Kelly","year":"2016","journal-title":"J Psychiatr Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/mp.2016.44","article-title":"Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism","volume":"21","author":"Zheng","year":"2016","journal-title":"Mol Psychiatry."},{"key":"B74","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging."},{"key":"B75","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","article-title":"Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats","volume":"128","author":"Holmqvist","year":"2014","journal-title":"Acta Neuropathol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"34477","DOI":"10.1038\/srep34477","article-title":"Exposure to the functional bacterial amyloid protein curli enhances alpha-synuclein aggregation in aged fischer 344 rats and Caenorhabditis elegans","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell."},{"key":"B78","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","article-title":"Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway","volume":"70","author":"Sun","year":"2018","journal-title":"Brain Behav Immun."},{"key":"B79","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson's disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov Disord."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.665520\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T04:46:17Z","timestamp":1630989977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.665520\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,7]]},"references-count":79,"alternative-id":["10.3389\/fmed.2021.665520"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.665520","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,7]]},"article-number":"665520"}}